These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7034933)
1. Phase I study of high-dose mitomycin with autologous bone marrow support. Sarna GP; Champlin R; Wells J; Gale RP Cancer Treat Rep; 1982 Feb; 66(2):277-82. PubMed ID: 7034933 [No Abstract] [Full Text] [Related]
2. Phase I-II study of high-dose mitomycin with autologous bone marrow transplantation in refractory metastatic breast cancer. Tannir N; Spitzer G; Dicke K; Schell F; DiStefano A; Blumenschein G Cancer Treat Rep; 1984 May; 68(5):805-6. PubMed ID: 6426793 [No Abstract] [Full Text] [Related]
4. High-dose mitomycin-C with autologous bone marrow transplantation in patients with refractory malignancies. Influence of dose schedule on pharmacokinetics and nonhematopoietic toxicities. Karanes C; Ratanatharathorn V; Schilcher RB; Young JD; Emmer D; Hoschner JA; Leichman L; Baker LH Am J Clin Oncol; 1986 Oct; 9(5):444-8. PubMed ID: 3096129 [TBL] [Abstract][Full Text] [Related]
5. Hepatic veno-occlusive disease after high-dose mitomycin C and autologous bone marrow transplantation therapy. Gottfried MR; Sudilovsky O Hum Pathol; 1982 Jul; 13(7):646-50. PubMed ID: 6806170 [TBL] [Abstract][Full Text] [Related]
6. Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantation. Lazarus HM; Gottfried MR; Herzig RH; Phillips GL; Weiner RS; Sarna GP; Fay J; Wolff SN; Sudilovsky O; Gale RP; Herzig GP Cancer; 1982 May; 49(9):1789-95. PubMed ID: 7042075 [TBL] [Abstract][Full Text] [Related]
7. Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report. DeFuria MD; Bracken RB; Johnson DE; Soloway MS; Merrin CE; Morgan LR; Miller HC; Crooke ST Cancer Treat Rep; 1980; 64(2-3):225-30. PubMed ID: 7407754 [TBL] [Abstract][Full Text] [Related]
8. Phase I study of the combination of iv mitomycin and oral metronidazole. Pfeffer MR; Sulkes A; Peretz TY; Fuks Z; Catane R Cancer Treat Rep; 1984 Sep; 68(9):1191-2. PubMed ID: 6478454 [No Abstract] [Full Text] [Related]
9. Mitomycin C: phase I study of a constant infusion ambulatory treatment schedule. Lokich J; Perri J; Fine N; Bothe A; Nelson T; Greene R; Zipoli T Am J Clin Oncol; 1982 Aug; 5(4):443-7. PubMed ID: 7113965 [TBL] [Abstract][Full Text] [Related]
10. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer. Peters WP; Ross M; Vredenburgh JJ; Hussein A; Rubin P; Dukelow K; Cavanaugh C; Beauvais R; Kasprzak S Semin Oncol; 1994 Aug; 21(4 Suppl 7):25-31. PubMed ID: 7916487 [TBL] [Abstract][Full Text] [Related]
11. [Use of bone marrow transplantation in the treatment of gastric cancer and its evaluation with special reference to anerobic Corynebacterium]. Hattori T; Yagi H; Murakami H; Ushijima K; Mori A Gan No Rinsho; 1969 Jan; 15(1):39-47. PubMed ID: 4888575 [No Abstract] [Full Text] [Related]
12. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients. Bentley SA; Brecher ME; Powell E; Serody JS; Wiley JM; Shea TC Bone Marrow Transplant; 1997 Mar; 19(6):557-63. PubMed ID: 9085735 [TBL] [Abstract][Full Text] [Related]
13. High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trial. Stiff PJ; Bayer R; Tan S; Camarda M; Sosman J; Peace D; Kinch L; Rad N; Loutfi S Clin Cancer Res; 1995 Dec; 1(12):1495-502. PubMed ID: 9815949 [TBL] [Abstract][Full Text] [Related]
14. [From bone marrow transplantation to blood stem cell transplantation. Experiences from the first 100 autologous stem cell transplantation in Turku]. Remes K; Rajamäki A; Grenman S; Itälä M; Kauppila M; Nikoskelainen J; Pelliniemi TT; Ristamäki R; Salmi TT; Salmi T; Salminen E; Vanharanta R; Toivanen A Duodecim; 1997; 113(3):219-28. PubMed ID: 11370030 [No Abstract] [Full Text] [Related]
15. [High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich]. Jost LM; Honegger HP; Stahel RA Schweiz Med Wochenschr; 2000 Jan; 130(3):60-9. PubMed ID: 10683881 [TBL] [Abstract][Full Text] [Related]
16. Long-term culture of autologous bone marrow for marrow reconstitution following high-dose chemotherapy. Purging with tumor surface antigen directed human-human monoclonal antibody. Alonso K; Medenica R; Morehead G Prog Clin Biol Res; 1994; 389():111-8. PubMed ID: 7700892 [No Abstract] [Full Text] [Related]
17. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study. Lazarus HM; Gray R; Ciobanu N; Winter J; Weiner RS Bone Marrow Transplant; 1994 Sep; 14(3):443-8. PubMed ID: 7994270 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of cancer with high-dose chemotherapy and autologous stem cell transplantation]. Geisler CH; Daugaard KG; Dickmeiss E; Ifversen M; Knudsen LM Ugeskr Laeger; 2003 Dec; 165(50):4846-9. PubMed ID: 14716902 [No Abstract] [Full Text] [Related]
19. Psychological stress symptoms before and after autologous bone marrow transplantation in patients with solid tumors. Grassi L; Rosti G; Albertazzi L; Marangolo M Bone Marrow Transplant; 1996 May; 17(5):843-7. PubMed ID: 8733707 [TBL] [Abstract][Full Text] [Related]
20. [High-dose chemotherapy and autologous bone marrow transplantation in solid tumors. A review]. Handberg J; Hansen SW Ugeskr Laeger; 1996 Jul; 158(29):4175-80. PubMed ID: 8701532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]